ES2150925T3 - Productos alimenticios y piensos que contienen inhibidores de la lipasa. - Google Patents

Productos alimenticios y piensos que contienen inhibidores de la lipasa.

Info

Publication number
ES2150925T3
ES2150925T3 ES93109449T ES93109449T ES2150925T3 ES 2150925 T3 ES2150925 T3 ES 2150925T3 ES 93109449 T ES93109449 T ES 93109449T ES 93109449 T ES93109449 T ES 93109449T ES 2150925 T3 ES2150925 T3 ES 2150925T3
Authority
ES
Spain
Prior art keywords
lipase inhibitors
food products
feed containing
containing lipase
feed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93109449T
Other languages
English (en)
Inventor
Dorothea Isler
Walter Rehm
Erich Widmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2150925T3 publication Critical patent/ES2150925T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Sustainable Development (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Feed For Specific Animals (AREA)

Abstract

APLICACION DE BIOMASA ORIGINADA EN LA PRODUCCION FERMENTATIVA DE INHIBIDORES DE LIPASA PARTICULARMENTE LIPSTATINA, EN LA PRODUCCION DE PRODUCTOS ALIMENTICIOS, PIENSOS ADITIVOS DE PRODUCTOS ALIMENTICIOS Y DE MEZCLAS Y PREMEZCLAS DE PIENSOS MEDICINALES, PIENSOS COMPLEMENTARIOS O MEDICAMENTOS DE ADMINISTRACION DOSIFICADA POR VIA ORAL.
ES93109449T 1992-06-24 1993-06-14 Productos alimenticios y piensos que contienen inhibidores de la lipasa. Expired - Lifetime ES2150925T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH199092 1992-06-24

Publications (1)

Publication Number Publication Date
ES2150925T3 true ES2150925T3 (es) 2000-12-16

Family

ID=4223335

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93109449T Expired - Lifetime ES2150925T3 (es) 1992-06-24 1993-06-14 Productos alimenticios y piensos que contienen inhibidores de la lipasa.

Country Status (13)

Country Link
US (2) US5447953A (es)
EP (1) EP0575846B1 (es)
JP (1) JP3390846B2 (es)
AT (1) ATE196721T1 (es)
AU (1) AU667106B2 (es)
CA (1) CA2098167C (es)
DE (1) DE59310110D1 (es)
DK (1) DK0575846T3 (es)
ES (1) ES2150925T3 (es)
GR (1) GR3035161T3 (es)
NZ (1) NZ247927A (es)
PT (1) PT575846E (es)
ZA (1) ZA934351B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0825891B2 (ja) * 1993-06-25 1996-03-13 株式会社薬理学中央研究所 脱脂米胚芽由来のリパーゼインヒビター
MY116591A (en) * 1996-04-26 2004-02-28 Hoffmann La Roche Process for the production of lipstatin and tetrahydrolipstatin
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
YU34199A (sh) * 1997-02-05 2002-08-12 F. Hoffmann-La Roche Ag. Primena inhibitora gastrointestinalne lipaze
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
GB9800912D0 (en) * 1998-01-17 1998-03-11 Danbiosyst Uk New composition
BR9911556A (pt) * 1998-06-26 2001-03-20 Iams Company Uso de l-carnitina; composição para promover perda de peso em um cão; e; suplemento alimentìcio para um cão.
WO2000009123A1 (en) * 1998-08-14 2000-02-24 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors and chitosan
BR9912980B1 (pt) * 1998-08-14 2013-10-22 Composição farmacêutica administrável oralmente, tablete de mascar contendo a mesma e utilização da mesma
WO2000013667A1 (en) * 1998-09-08 2000-03-16 Smithkline Beecham Corporation Lipstatin derivative-soluble fiber tablets
US7001618B1 (en) 1999-07-09 2006-02-21 The Iams Company Nutritional composition for weight management
US6630159B2 (en) * 1999-02-23 2003-10-07 The Procter & Gamble Company Limiting weight gain of cats by feeding carbohydrate source that excludes rice
US6235305B1 (en) * 1999-10-29 2001-05-22 2Pro Chemical Essentially nonabsorbable lipase inhibitor derivatives, pharmaceutical compositions and methods of use therefor
AU2001289696B2 (en) * 2000-07-28 2006-07-06 Cheplapharm Arzneimittel Gmbh New use of lipase inhibitors
NZ523684A (en) * 2000-07-28 2005-04-29 F New pharmaceutical composition
US6251421B1 (en) * 2000-09-25 2001-06-26 Sarfaraz K. Niazi Pharmaceutical composition containing psyllium fiber and a lipase inhibitor
US20030091610A1 (en) * 2001-03-19 2003-05-15 The Procter & Gamble Company Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
US20030072804A1 (en) * 2001-03-19 2003-04-17 The Procter & Gamble Company Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
EP1501498B1 (en) 2002-04-26 2009-12-30 F. Hoffmann-La Roche Ag Pharmaceutical composition comprising a lipase inhibitor and glucomannan
US8372430B2 (en) * 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
WO2006056845A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
CA2617654A1 (en) * 2005-08-04 2007-02-08 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2007096763A2 (en) * 2006-02-23 2007-08-30 Pfizer Limited Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
AR063275A1 (es) * 2006-10-12 2009-01-14 Epix Delaware Inc Compuestos de carboxamida, una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la activacion de ccr2.
KR20090064478A (ko) 2006-11-13 2009-06-18 화이자 프로덕츠 인크. 디아릴, 디피리디닐 및 아릴-피리디닐 유도체, 및 이들의 용도
JP2010510201A (ja) * 2006-11-20 2010-04-02 グレンマーク・ファーマシューティカルズ・エスエー ステアリン酸ＣｏＡ脱飽和酵素阻害剤としてのアセチレン誘導体
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
WO2009037542A2 (en) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Spirocyclic compounds as stearoyl coa desaturase inhibitors
CN101925383A (zh) 2007-12-11 2010-12-22 赛特帕斯凡德株式会社 甲酰胺化合物及其作为趋化因子受体激动剂的应用
JP5530438B2 (ja) * 2008-08-06 2014-06-25 ファイザー・リミテッド Ｍｃ４作動薬としてのジアゼピンおよびジアゾカン化合物
US8309107B2 (en) * 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
EP2571860A1 (en) 2010-05-21 2013-03-27 Pfizer Inc 2-phenyl benzoylamides
WO2012070702A1 (ko) * 2010-11-25 2012-05-31 주식회사 삼양사 올리스태트 및 키토산 함유 조성물 및 그 제조방법
JP2014513923A (ja) 2011-03-04 2014-06-19 ファイザー・インク Ｅｄｎ３様ペプチドおよびその使用
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA2975217C (en) 2015-02-13 2023-08-15 Mars, Incorporated Pet food feeding system
WO2017014620A1 (es) * 2015-07-23 2017-01-26 Laboratorios Minkab, S.A. De C.V. Suplemento alimenticio a base de ferulato de etilo
EP3911648A4 (en) 2019-01-18 2022-10-26 Astrazeneca AB PCSK9 INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE404874C (de) * 1922-04-22 1924-11-01 Siemens Schuckertwerke G M B H UEberwachungseinrichtung fuer Gleichrichter
US2462275A (en) * 1942-11-02 1949-02-22 Rca Corp Electronic computer
US3462275A (en) * 1968-01-31 1969-08-19 Gen Electric Waste conversion process and product
US4211765A (en) * 1971-10-12 1980-07-08 Monsanto Company Method for controlling obesity
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) * 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
US4302450A (en) * 1979-01-15 1981-11-24 Hoffmann-La Roche Inc. Polyether ionophores as antiobesity and hypotriglyceridemic agents
US4218443A (en) * 1979-01-15 1980-08-19 Hoffmann-La Roche Inc. Polyether ionophores as antiobesity and hypotriglyceridemic agents
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
GB2239455B (en) * 1989-12-25 1993-12-15 Nisshin Flour Milling Co Formulations of lipolytic enzyme inhibitors and use of said inhibitors
US5260310A (en) * 1990-02-26 1993-11-09 Hoffmann-La Roche Inc. Oxetanone compounds and pharmaceutical compositions containing them
IL97148A (en) * 1990-02-26 1996-11-14 Hoffmann La Roche Oxtanones, the process for their preparation and the pharmaceutical preparations containing them

Also Published As

Publication number Publication date
US5540917A (en) 1996-07-30
PT575846E (pt) 2001-01-31
JPH0662758A (ja) 1994-03-08
ZA934351B (en) 1993-12-27
DK0575846T3 (da) 2001-01-08
AU667106B2 (en) 1996-03-07
AU4139693A (en) 1994-01-06
GR3035161T3 (en) 2001-04-30
CA2098167C (en) 2006-12-19
EP0575846A3 (de) 1994-12-21
DE59310110D1 (de) 2000-11-09
EP0575846B1 (de) 2000-10-04
EP0575846A2 (de) 1993-12-29
JP3390846B2 (ja) 2003-03-31
US5447953A (en) 1995-09-05
NZ247927A (en) 1995-09-26
ATE196721T1 (de) 2000-10-15
CA2098167A1 (en) 1993-12-25

Similar Documents

Publication Publication Date Title
ES2150925T3 (es) Productos alimenticios y piensos que contienen inhibidores de la lipasa.
ES2168157T3 (es) Alimento o suplemento nutritivo, su procedimiento de preparacion y sus utilizaciones.
DE69124223D1 (de) Vitamine und mineralien enthaltende nahrungszusätze
IL146438A0 (en) Process and product for enhancing immune response in companion animal using a combination of antioxidants
BR9711054B1 (pt) composição de suplemento dietético para fornecer sacarìdeos de produtos nutritivos.
DE60036000D1 (de) Gelartige nahrungszusammensetzung
ES2171535T3 (es) Producto nutritivo utilizado en el tratamiento de la colitis ulcerosa y su uso.
CA2105791A1 (en) Nutrition for Persons Undergoing Radiation Therapy and/or Chemotherapy
PT1063901E (pt) Alimentos contendo biotina e outras vitaminas b
IT1225239B (it) Additivo al magnesio per sostanze nutritive, alimenti e medicamenti
HUP0000042A2 (hu) Omega-3-zsírsavat és vitamint tartalmazó hústermékek
ATE217494T1 (de) Orale darreichungsform
ATE178615T1 (de) Verwendung eines dekapeptids mit benzodiazepinischer wirkung zur herstellung von arzneimitteln und diätzusätzen
MA22666A1 (fr) Production de produits alimentaires fermentes .
ATE186817T1 (de) Herstellung von fettsäuresalz-diätprodukten
EP1143945A3 (en) Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry
RU93012680A (ru) Белково-витаминно-минеральная добавка для свиней
RU93011685A (ru) Штамм актиномицета streptomyces ornatus - продуцент внеклеточного кератинрасщепляющего фермента

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 575846

Country of ref document: ES